DE69904738D1 - 2-phenylpyran-4-one derivate - Google Patents

2-phenylpyran-4-one derivate

Info

Publication number
DE69904738D1
DE69904738D1 DE69904738T DE69904738T DE69904738D1 DE 69904738 D1 DE69904738 D1 DE 69904738D1 DE 69904738 T DE69904738 T DE 69904738T DE 69904738 T DE69904738 T DE 69904738T DE 69904738 D1 DE69904738 D1 DE 69904738D1
Authority
DE
Germany
Prior art keywords
phenylpyrane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69904738T
Other languages
English (en)
Other versions
DE69904738T2 (de
Inventor
Crespo M Isabel Crespo
Mayorga Juan Miguel Jimenez
Duran Carles Puig
Pueyo Lidia Soca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9802011A external-priority patent/ES2154561B1/es
Priority claimed from ES009900619A external-priority patent/ES2168895A1/es
Application filed by Almirall Prodesfarma AG filed Critical Almirall Prodesfarma AG
Publication of DE69904738D1 publication Critical patent/DE69904738D1/de
Application granted granted Critical
Publication of DE69904738T2 publication Critical patent/DE69904738T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69904738T 1998-09-25 1999-09-16 2-phenylpyran-4-one derivate Expired - Lifetime DE69904738T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES9802011A ES2154561B1 (es) 1998-09-25 1998-09-25 Derivados de 2-fenilpiran-4-ona.
ES009900619A ES2168895A1 (es) 1999-03-26 1999-03-26 Derivados de 2-fenilpiran-4-ona.
PCT/EP1999/006873 WO2000018753A1 (en) 1998-09-25 1999-09-16 2-phenylpyran-4-one derivatives

Publications (2)

Publication Number Publication Date
DE69904738D1 true DE69904738D1 (de) 2003-02-06
DE69904738T2 DE69904738T2 (de) 2003-04-30

Family

ID=26155180

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69904738T Expired - Lifetime DE69904738T2 (de) 1998-09-25 1999-09-16 2-phenylpyran-4-one derivate

Country Status (34)

Country Link
US (1) US6518303B2 (de)
EP (1) EP1115716B1 (de)
JP (1) JP4717211B2 (de)
KR (1) KR100806684B1 (de)
CN (1) CN1202104C (de)
AR (1) AR021826A1 (de)
AT (1) ATE230405T1 (de)
AU (1) AU765653B2 (de)
BG (1) BG65308B1 (de)
BR (1) BR9913939A (de)
CA (1) CA2345069C (de)
CO (1) CO5140127A1 (de)
CZ (1) CZ300357B6 (de)
DE (1) DE69904738T2 (de)
DK (1) DK1115716T3 (de)
EE (1) EE04812B1 (de)
EG (1) EG23802A (de)
ES (1) ES2190252T3 (de)
HK (1) HK1034961A1 (de)
HU (1) HUP0104620A3 (de)
ID (1) ID28624A (de)
IL (1) IL142087A0 (de)
MX (1) MXPA01003069A (de)
MY (1) MY121793A (de)
NO (1) NO327987B1 (de)
NZ (1) NZ510625A (de)
PE (1) PE20001067A1 (de)
PL (1) PL346895A1 (de)
RU (1) RU2232158C2 (de)
SI (1) SI1115716T1 (de)
SK (1) SK286471B6 (de)
TR (1) TR200100852T2 (de)
TW (1) TW587079B (de)
WO (1) WO2000018753A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011333A1 (es) * 2000-03-16 2002-01-16 Almirall Prodesfarma Ag Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
ES2214129B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2213485B1 (es) * 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
ES2214130B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 2-3'-bipiridinas.
US20040220155A1 (en) * 2003-03-28 2004-11-04 Pharmacia Corporation Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US304728A (en) * 1884-09-09 Maubice hellwig
CH524612A (de) * 1969-12-31 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Imidazolderivaten
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
US4304728A (en) * 1979-04-05 1981-12-08 Lilly Industries Limited 6-Substituted pyranone compounds and their use as pharmaceuticals
IL59748A (en) 1979-04-05 1983-11-30 Lilly Industries Ltd 5-substituted pyranone derivatives,their production and pharmaceutical compositions containing them
JPS5834446B2 (ja) * 1979-05-22 1983-07-27 三省製薬株式会社 消炎剤
JPH0768234B2 (ja) * 1989-12-14 1995-07-26 久光製薬株式会社 コウジ酸エステル誘導体
ATE128128T1 (de) * 1990-06-29 1995-10-15 Upjohn Co Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
JPH04173391A (ja) * 1990-11-07 1992-06-22 Sanyo Chem Ind Ltd 感熱記録用増感剤および感熱記録用材料
DE4103904C2 (de) * 1991-02-08 1995-06-14 Analyticon Ges Fuer Chemische Neue Arzneimittel aus Gamma-Pyronen, Gamma-Pyridonen sowie Gamma-Thiopyronen
US6048850A (en) 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
EP0729466A1 (de) * 1993-11-19 1996-09-04 PARKE, DAVIS & COMPANY Pyron derivate als protease inhibitoren und antivirusmittel
US5521213A (en) * 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
HUP9801602A3 (en) 1995-04-04 1999-01-28 Glaxo Group Ltd Imidazo[1,2-a]pyridine derivatives, process for their production, pharmaceutical compositions and use thereof
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
PT1043317E (pt) * 1997-11-19 2009-05-11 Kowa Co Novos derivados de piridazina e fármacos que os contêm como ingrediente activo

Also Published As

Publication number Publication date
BG105373A (en) 2001-11-30
EE200100173A (et) 2002-08-15
DK1115716T3 (da) 2003-02-24
BG65308B1 (bg) 2008-01-31
MY121793A (en) 2006-02-28
US20020045644A1 (en) 2002-04-18
CA2345069C (en) 2009-03-10
AU6084799A (en) 2000-04-17
AR021826A1 (es) 2002-08-07
EP1115716B1 (de) 2003-01-02
ES2190252T3 (es) 2003-07-16
CA2345069A1 (en) 2000-04-06
CO5140127A1 (es) 2002-03-22
CN1324352A (zh) 2001-11-28
MXPA01003069A (es) 2002-07-02
HK1034961A1 (en) 2001-11-09
JP4717211B2 (ja) 2011-07-06
US6518303B2 (en) 2003-02-11
DE69904738T2 (de) 2003-04-30
EE04812B1 (et) 2007-04-16
NO20011512L (no) 2001-05-25
PL346895A1 (en) 2002-03-11
RU2232158C2 (ru) 2004-07-10
IL142087A0 (en) 2002-03-10
AU765653B2 (en) 2003-09-25
CZ300357B6 (cs) 2009-04-29
HUP0104620A3 (en) 2003-01-28
NO327987B1 (no) 2009-11-02
CN1202104C (zh) 2005-05-18
NZ510625A (en) 2002-12-20
EP1115716A1 (de) 2001-07-18
TW587079B (en) 2004-05-11
SK3702001A3 (en) 2001-12-03
EG23802A (en) 2007-08-22
JP2002525364A (ja) 2002-08-13
SI1115716T1 (en) 2003-06-30
TR200100852T2 (tr) 2001-10-22
WO2000018753A1 (en) 2000-04-06
NO20011512D0 (no) 2001-03-23
BR9913939A (pt) 2001-06-12
KR20010075369A (ko) 2001-08-09
HUP0104620A2 (hu) 2002-04-29
CZ20011058A3 (cs) 2001-08-15
SK286471B6 (sk) 2008-11-06
ATE230405T1 (de) 2003-01-15
PE20001067A1 (es) 2000-10-23
KR100806684B1 (ko) 2008-02-26
ID28624A (id) 2001-06-21

Similar Documents

Publication Publication Date Title
ATE261933T1 (de) Admantan derivate
DE69706292T2 (de) Chinazoline derivate
NO20010193L (no) Tiobenzimidazol-derivater
ATE236136T1 (de) Benzosulfonderivate
ATE259810T1 (de) Phenyl-xanthinderivate
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
DE60013127D1 (de) 5-phenyl-pyrimidine derivate
DE69928262D1 (de) Substituierte chinazoline derivate
ATE233746T1 (de) Thiazole derivate
ATE277917T1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
ATE298760T1 (de) 2-halo-6-0-substituierte ketolide derivate
DE60025918D1 (de) 4-phenyl-pyrimidine derivate
PT1056716E (pt) Derivados de ciclo-hexanodiolo
ATE230405T1 (de) 2-phenylpyran-4-one derivate
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DK1060183T3 (da) 5-deoxycytidinderivater
ATE219051T1 (de) 5-aroylnaphthalin derivate
DE69917058D1 (de) Thiazole derivate
DE69838303D1 (de) Hydroxyprolin derivate
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate
PT928793E (pt) Derivados de tiazol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ALMIRALL AG, BAAR, CH

8327 Change in the person/name/address of the patent owner

Owner name: LABORATORIOS ALMIRALL, S.A., BARCELONA, ES